LIDOVIR- acyclovir and lidocaine hydrochloride
Allegis Pharmaceuticals, LLC
----------
LidoVir Ointment Compounding Kit
Preparation Instructions
Acyclovir 4%, Lidocaine HCl 4% in White Petrolatum
FOR PRESCRIPTION COMPOUNDING ONLY
Each LidoVir Ointment Compounding Kit provides 2.48 grams of micronized Lidocaine HCl, and 2.48 grams of micronized Acyclovir powder USP1 for incorporation into 57.2 grams of White Petrolatum. The resulting mixture is intended for topical use.
1 color coded blue bottle of 2.48g Acyclovir, 1 color coded red bottle of 2.48g Lidocaine HCl, 2 color coded orange tubes of White Petrolatum, 1 stirring stick, 1 empty white mixing jar.
|
Prior to compounding, store LidoVir Ointment Compounding Kit at room temperature between 15 – 30 degrees C (59 – 86 degrees F).
LidoVir Ointment Compounding Kit components have a two-year expiration date.
For external use only. Avoid contact with eyes. Keep container tightly closed. Keep out of reach of children. Protect from light. Dispose of product after 30 days of being compounded.
Size | 62.2 grams |
NDC# | 28595-973-62 |
Lidocaine HCl, USP | 2.48 grams |
Acyclovir, USP | 2.48 grams |
White Petrolatum | 57.2 grams |
The FDA has not approved LidoVir Ointment to cure, treat, or mitigate disease. LidoVir Ointment is intended for preparation in accordance with state and federal regulation governing compounding and is available to patients by prescription only.
Rx ONLY
Marketed by: Sircle Laboratories, Jackson, MS 39046
LidoVir™ Ointment
Acyclovir 4%/Lidocaine 4%
In White Petrolatum Compounding Kit
NDC 28595-973-62
Rx Only
LidoVir™ Ointment
Acyclovir 4%/Lidocaine HCl 4%
In White Petrolatum Compounding Kit
Acyclovir 4%
Lidocaine HCl 4%
Compounding Kit for Prescription Compounding Only
Each kit contains:
Acyclovir 2.48g
Lidocaine HCl 2.48g
White Petrolatum 57.2g
Topical
Ointment
62.2 g (as dispensed)
SIRCLE
Laboratories
LIDOVIR
acyclovir and lidocaine hydrochloride kit |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Allegis Pharmaceuticals, LLC (792272861) |